The female genital system encompasses various aspects of anatomical and pathological classifications which are crucial for understanding gynecological conditions. The main areas covered include:
Pathology of the vulva and vagina (682-685)
Pathology of the cervix (685-689)
Pathology of the uterine body (689-694)
Pathology of the ovaries and fallopian tubes (695-700)
Understanding the anatomical terms is essential for grasping pathology descriptions. Here are some terms and their translations:
Uterus (uter, utérus)
Urinary Bladder (vezică urinară, vessie)
Cervix (col uterin, col de l'uterus)
Vagina (vagin)
Fallopian Tube (trompă uterină, trompes de Fallope)
Ovary (ovar, ovaire)
Vulva (vulvă, vulve)
Clitoris (clitoris)
Edema: Often due to conditions like hipoalbuminemia.
Varices: Can arise from pelvic tumors or pregnancy.
Perineal Rupture: Often occurs during childbirth.
Acute: Can be caused by infections like Trichomonas, Candida, and bacteria (e.g. gonorrhea).
Chronic Non-infectious: Related to poor hygiene, diabetes, and vitamin deficiencies.
Dermatitis: Allergic reactions to sprays or gels can lead to contact dermatitis.
Vulvovaginitis: Often indicates the involvement of Herpes virus or HPV (e.g. condylomata acuminata).
Benign: Include papillomas, condylomas, fibromas.
Premalignant: Conditions like lichen sclerosus or hyperplastic lesions may carry a risk for progression to malignancy.
Malignant: Invasive squamous cell carcinoma is a significant concern for women, particularly those with HPV infections.
Hematokolpos: Occurs with hymenal atresia.
Senile Atrophy: Leads to decreased hormonal stimulation affecting older women.
Birth Trauma or Assault: Can lead to serious damage.
Rare cases of malignant conditions such as vaginal carcinoma.
Acute: Can manifest as catarrhal or purulent, usually infection-induced.
Chronic: Often involves metaplastic changes, retention cysts (Nabothian cysts), and can arise from hormonal changes associated with contraceptive use.
Neoplasias Intraepiteliale Cervicală (CIN): Classifications range from CIN I (low-grade) to CIN III (high-grade dysplasia).
HPV Risk Groups: Vary from low-risk types (like 6, 11) to high-risk types (like 16, 18) which are associated with cervical cancer.
Benign: Include cervical polyps.
Malignant: Primary corroboration with squamous cell carcinoma increasingly prevalent, often informed by HPV status.
Used to convey the extent of the disease for effective treatment planning.
Endometritis: Can be acute following miscarriage or childbirth, with various therapeutic challenges if chronic.
Endometriosis: Characterized by the presence of endometrial tissue outside the uterus, can cause departmental pain or infertility.
Leiomyoma: Common benign tumor affecting women of reproductive age.
Endometrial Carcinoma: Must be distinguished as type I (often estrogen-driven) or type II (often atrophic).
Variability in aggressiveness and hormonal response necessitates tailored treatments based on tumor types and stages.
Acute: Often associated with infections that may ascend from the uterus.
Chronic: Results in scarring and the formation of adhesions, leading to complications such as infertility.
Benign Ovarian Tumors: Often cystic and include serous or mucinous types; typically asymptomatic until large.
Malignant Tumors: Early detection is crucial, commonly arising from surface epithelial tumors and necessitating thorough staging and possible surgical intervention.
In summary, the pathology of the female genital system includes a wide array of conditions impacting the vulva, vagina, cervix, uterus, and ovaries. Understanding these pathological processes is key in the clinical context to ensure accurate diagnosis, appropriate management, and treatment outcomes in gynecological practices.